448 related articles for article (PubMed ID: 28404377)
1. H
Untereiner AA; Oláh G; Módis K; Hellmich MR; Szabo C
Biochem Pharmacol; 2017 Jul; 136():86-98. PubMed ID: 28404377
[TBL] [Abstract][Full Text] [Related]
2. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.
Druzhyna N; Szczesny B; Olah G; Módis K; Asimakopoulou A; Pavlidou A; Szoleczky P; Gerö D; Yanagi K; Törö G; López-García I; Myrianthopoulos V; Mikros E; Zatarain JR; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):18-37. PubMed ID: 27521834
[TBL] [Abstract][Full Text] [Related]
3. Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro.
Módis K; Coletta C; Asimakopoulou A; Szczesny B; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
Nitric Oxide; 2014 Sep; 41():146-56. PubMed ID: 24667534
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer.
Szabo C; Coletta C; Chao C; Módis K; Szczesny B; Papapetropoulos A; Hellmich MR
Proc Natl Acad Sci U S A; 2013 Jul; 110(30):12474-9. PubMed ID: 23836652
[TBL] [Abstract][Full Text] [Related]
5. Endogenous H
Wang C; Du J; Du S; Liu Y; Li D; Zhu X; Ni X
Mol Cell Endocrinol; 2018 Oct; 474():65-73. PubMed ID: 29486221
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance induces the upregulation of H
Untereiner AA; Pavlidou A; Druzhyna N; Papapetropoulos A; Hellmich MR; Szabo C
Biochem Pharmacol; 2018 Mar; 149():174-185. PubMed ID: 29061341
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide perturbs mitochondrial bioenergetics and triggers metabolic reprogramming in colon cells.
Libiad M; Vitvitsky V; Bostelaar T; Bak DW; Lee HJ; Sakamoto N; Fearon E; Lyssiotis CA; Weerapana E; Banerjee R
J Biol Chem; 2019 Aug; 294(32):12077-12090. PubMed ID: 31213529
[TBL] [Abstract][Full Text] [Related]
8. S-Sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics.
Módis K; Ju Y; Ahmad A; Untereiner AA; Altaany Z; Wu L; Szabo C; Wang R
Pharmacol Res; 2016 Nov; 113(Pt A):116-124. PubMed ID: 27553984
[TBL] [Abstract][Full Text] [Related]
9. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
[TBL] [Abstract][Full Text] [Related]
10. Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation.
Oláh G; Módis K; Törö G; Hellmich MR; Szczesny B; Szabo C
Biochem Pharmacol; 2018 Mar; 149():186-204. PubMed ID: 29074106
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological actions of the slow release hydrogen sulfide donor GYY4137 on phenylephrine-induced tone in isolated bovine ciliary artery.
Chitnis MK; Njie-Mbye YF; Opere CA; Wood ME; Whiteman M; Ohia SE
Exp Eye Res; 2013 Nov; 116():350-4. PubMed ID: 24145109
[TBL] [Abstract][Full Text] [Related]
12. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
Ždralević M; Brand A; Di Ianni L; Dettmer K; Reinders J; Singer K; Peter K; Schnell A; Bruss C; Decking SM; Koehl G; Felipe-Abrio B; Durivault J; Bayer P; Evangelista M; O'Brien T; Oefner PJ; Renner K; Pouysségur J; Kreutz M
J Biol Chem; 2018 Oct; 293(41):15947-15961. PubMed ID: 30158244
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release.
Tang B; Ma L; Yao X; Tan G; Han P; Yu T; Liu B; Sun X
J Vasc Surg; 2017 Feb; 65(2):501-508.e1. PubMed ID: 26781077
[TBL] [Abstract][Full Text] [Related]
14. Exogenous Hydrogen Sulfide Attenuates Cardiac Fibrosis Through Reactive Oxygen Species Signal Pathways in Experimental Diabetes Mellitus Models.
Zheng D; Dong S; Li T; Yang F; Yu X; Wu J; Zhong X; Zhao Y; Wang L; Xu C; Lu F; Zhang W
Cell Physiol Biochem; 2015; 36(3):917-29. PubMed ID: 26088607
[TBL] [Abstract][Full Text] [Related]
15. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
[TBL] [Abstract][Full Text] [Related]
16. Unappreciated Role of LDHA and LDHB to Control Apoptosis and Autophagy in Tumor Cells.
Urbańska K; Orzechowski A
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035592
[TBL] [Abstract][Full Text] [Related]
17. GYY4137, a novel hydrogen sulfide-releasing molecule, likely protects against high glucose-induced cytotoxicity by activation of the AMPK/mTOR signal pathway in H9c2 cells.
Wei WB; Hu X; Zhuang XD; Liao LZ; Li WD
Mol Cell Biochem; 2014 Apr; 389(1-2):249-56. PubMed ID: 24374752
[TBL] [Abstract][Full Text] [Related]
18. The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury.
Jensen AR; Drucker NA; Te Winkel JP; Ferkowicz MJ; Markel TA
J Pediatr Surg; 2018 Jun; 53(6):1111-1117. PubMed ID: 29622397
[TBL] [Abstract][Full Text] [Related]
19. H
Foster JC; Radzinski SC; Zou X; Finkielstein CV; Matson JB
Mol Pharm; 2017 Apr; 14(4):1300-1306. PubMed ID: 28300411
[TBL] [Abstract][Full Text] [Related]
20. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
